z-logo
open-access-imgOpen Access
Complete Regression of Choroidal Metastasis Secondary to Non-Small-Cell Lung Cancer with Intravitreal Bevacizumab and Oral Erlotinib Combination Therapy
Author(s) -
SeongWoo Kim,
MyeongJin Kim,
Kuhl Huh,
Jaeryung Oh
Publication year - 2009
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000229307
Subject(s) - bevacizumab , medicine , erlotinib , fluorescein angiography , lung cancer , metastasis , ophthalmology , visual acuity , lesion , brain metastasis , cancer , oncology , chemotherapy , surgery , epidermal growth factor receptor
To report a case of a complete regression of choroidal metastasis secondary to non-small-cell lung cancer (NSCLC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom